Literature DB >> 28195336

On beyond staging and grading: Liver biopsy evaluation in a posttreatment world.

David E Kleiner1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28195336      PMCID： PMC5397352          DOI： 10.1002/hep.29111

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  9 in total

1.  Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement.

Authors:  Yasuni Nakanuma; Yoh Zen; Kenichi Harada; Motoko Sasaki; Akitaka Nonomura; Takeshi Uehara; Kenji Sano; Fukuo Kondo; Toshio Fukusato; Koichi Tsuneyama; Masahiro Ito; Kenichi Wakasa; Minoru Nomoto; Hiroshi Minato; Hironori Haga; Masayoshi Kage; Hirohisa Yano; Joji Haratake; Shinichi Aishima; Tomoyuki Masuda; Hajime Aoyama; Aya Miyakawa-Hayashino; Toshiharu Matsumoto; Hayato Sanefuji; Hidenori Ojima; Tse-Ching Chen; Eunsil Yu; Ji-Hun Kim; Young Nyun Park; Wilson Tsui
Journal:  Pathol Int       Date:  2010-03       Impact factor: 2.534

Review 2.  Classification of chronic hepatitis: diagnosis, grading and staging.

Authors:  V J Desmet; M Gerber; J H Hoofnagle; M Manns; P J Scheuer
Journal:  Hepatology       Date:  1994-06       Impact factor: 17.425

3.  The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease.

Authors:  Victoria L Gadd; Richard Skoien; Elizabeth E Powell; Kevin J Fagan; Clay Winterford; Leigh Horsfall; Katharine Irvine; Andrew D Clouston
Journal:  Hepatology       Date:  2014-03-01       Impact factor: 17.425

4.  Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis.

Authors:  I R Wanless; E Nakashima; M Sherman
Journal:  Arch Pathol Lab Med       Date:  2000-11       Impact factor: 5.534

5.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

6.  New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment.

Authors:  Yameng Sun; Jialing Zhou; Lin Wang; Xiaoning Wu; Yongpeng Chen; Hongxin Piao; Lungen Lu; Wei Jiang; Youqing Xu; Bo Feng; Yuemin Nan; Wen Xie; Guofeng Chen; Huanwei Zheng; Hai Li; Huiguo Ding; Hui Liu; Fudong Lv; Chen Shao; Tailing Wang; Xiaojuan Ou; Bingqiong Wang; Shuyan Chen; Aileen Wee; Neil D Theise; Hong You; Jidong Jia
Journal:  Hepatology       Date:  2017-03-22       Impact factor: 17.425

7.  Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.

Authors:  Elizabeth M Brunt; David E Kleiner; Laura A Wilson; Aynur Unalp; Cynthia E Behling; Joel E Lavine; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

8.  Progression of fibrosis in chronic hepatitis C.

Authors:  Marc G Ghany; David E Kleiner; Harvey Alter; Edward Doo; Farooq Khokar; Kittichai Promrat; David Herion; Yoon Park; T Jake Liang; Jay H Hoofnagle
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

9.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425
  9 in total
  2 in total

1.  Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin.

Authors:  Mari Saif; Wilhelmus J Kwanten; Jessica A Carr; Ivy X Chen; Jessica M Posada; Amitabh Srivastava; Juanye Zhang; Yi Zheng; Matthias Pinter; Sampurna Chatterjee; Samir Softic; C Ronald Kahn; Klaus van Leyen; Oliver T Bruns; Rakesh K Jain; Moungi G Bawendi
Journal:  Nat Biomed Eng       Date:  2020-06-22       Impact factor: 25.671

Review 2.  Histopathological evaluation of liver fibrosis and cirrhosis regression.

Authors:  Regina C Lo; Haeryoung Kim
Journal:  Clin Mol Hepatol       Date:  2017-12-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.